Qvin

Active

Empowering women. Period.

Winter 2016Founded 201430 peopleMenlo Park, CA, USA

About

Qvin is the first and only healthcare service to scientifically prove menstrual blood can test for critical health information – just like a traditional laboratory blood test. Women's health has always been under-prioritized in science. We still operate in a world built by men, for men. It’s why in 2014, Dr. Sara Naseri and Søren Therkelsen started Qvin to research, develop, and patent a product that powers an underserved and understudied population—women. Over 70% of the decisions our doctors make are influenced by blood test results. Every month, 1.8 billion people across the world menstruate. However, the blood our bodies naturally deliver every month has never been explored as a testing source. And yet, menstrual blood has been left unexplored. Qvin is the first and only healthcare service to use period blood as a non-invasive blood test. We exist to give women an easy, insightful way to monitor existing health issues, proactively screen for others, and go into doctor visits more informed and confident of their own health. Our health technology platform helps women manage their health better through a non-invasive blood collection device named the Q-Pad™. All of us at Qvin want to move the study of women forward. We want to close the gender data gap. And we stand for every person who identifies with women, however they define it.

From their website

qvin.com ↗

API/InfraSubscription

Qvin develops non-invasive women's health diagnostics by using menstrual blood as a biomarker source. They offer the Q-Pad, an FDA-cleared at-home collection device that enables non-invasive health insights from menstrual blood, aiming to diagnose and monitor conditions without needles or invasive samples.

Qvin has created the Q-Pad, an FDA-cleared diagnostic menstrual pad that passively collects menstrual blood using an embedded dried sample strip. The collected samples can be analyzed to reveal biomarkers correlating with metabolic, hormonal, and reproductive health, with the goal of enabling at-home, needle-free health insights and potential non-invasive disease monitoring. The device is designed for use during menstruation and supports sampling from home to inform health decisions and early detection.

Who it’s for: People who menstruate interested in non-invasive health monitoring and early detection of gynecological and systemic conditions; diagnostic platforms, healthcare organizations, or country-level agencies interested in partnerships.

Features

FDA-cleared diagnostic menstrual pad
At-home, needle-free sample collection
Passively collects menstrual blood for biomarker analysis
Correlation of menstrual biomarkers with venous blood tests (e.g., HbA1c, TSH, AMH)
Supports monitoring metabolic, hormonal, and reproductive health
Biomarker-based insights for gynecological and systemic conditions

Careers/traction mentions; funding/collaboration invites; partnerships and collaborations emphasized